Publication Name	World Journal of Clinical Cases
Manuscript ID	88393
Country	Türkiye

Received	2023-09-22 16:36
Peer-Review Started	2023-09-22 16:38
To Make the First Decision
Return for Revision	2023-11-09 02:45
Revised	2023-11-10 20:41
Second Decision	2023-12-06 02:41
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-12-06 04:03
Articles in Press	2023-12-06 04:03
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-12-18 03:14
Publish the Manuscript Online	2023-12-22 08:49

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Retrospective Study
Article Title	Evaluation of response to gemcitabine plus cisplatin-based chemotherapy using positron emission computed tomography for metastatic bladder cancer
Manuscript Source	Unsolicited Manuscript
All Author List	Hakan Öztürk and İnanç Karapolat
ORCID	Author(s) ORCID Number Hakan Öztürk http://orcid.org/0000-0002-4962-7707
Funding Agency and Grant Number
Corresponding Author	Hakan Öztürk, MD, Adjunct Associate Professor, Associate Professor, Department of Urology, Izmir University of Economics, 1825 sok no 12 Medicalpoint Hospital , Karsiyaka Izmir 35330, Türkiye. drhakanozturk@yahoo.com.tr
Key Words	Metastatic bladder cancer; Response to chemotheraphy; Positron emission tomography computed tomography; 18FDG-PET/CT
Core Tip	18Fluorodeoxyglucose positron emission tomography computed tomography can be considered as a successful imaging tool in evaluating response to first-line chemotherapy for metastatic bladder cancer. Anatomical and functional data obtained from positron emission tomography computed tomography scans can be useful in the planning of second and third-line chemotherapy.
Publish Date	2023-12-22 08:49
Citation	Öztürk H, Karapolat İ. Evaluation of response to gemcitabine plus cisplatin-based chemotherapy using positron emission computed tomography for metastatic bladder cancer. World J Clin Cases 2023; 11(36): 8447-8457
URL	https://www.wjgnet.com/2307-8960/full/v11/i36/8447.htm
DOI	https://dx.doi.org/10.12998/wjcc.v11.i36.8447

Full Article (PDF)	WJCC-11-8447-with-cover.pdf
Full Article (Word)	WJCC-11-8447.docx
Manuscript File	88393_Auto_Edited-LJH-JLW.doc
Answering Reviewers	88393-Answering reviewers.pdf
Audio Core Tip	88393-Audio core tip.MOV
Conflict-of-Interest Disclosure Form	88393-Conflict-of-interest statement.pdf
Copyright License Agreement	88393-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	88393-Informed consent statement.pdf
Peer-review Report	88393-Peer-review(s).pdf
Scientific Misconduct Check	88393-Bing-Liu JH-2.png
Scientific Misconduct Check	88393-CrossCheck.png
Scientific Editor Work List	88393-Scientific editor work list.pdf
CrossCheck Report	88393-CrossCheck report.pdf